Cidara Therapeutics
0 sources
Financials
0001610618-25-000017Cidara Therapeutics
Summary
Cidara Therapeutics is a business[1].
Key Facts
- Cidara Therapeutics is in the country of United States[2].
- Cidara Therapeutics is in the country of US[3].
- Cidara Therapeutics's instance of is recorded as business[4].
- Cidara Therapeutics's instance of is recorded as public company[5].
- Cidara Therapeutics's headquarters location is recorded as San Diego[6].
- Cidara Therapeutics's stock exchange is recorded as Nasdaq[7].
- Cidara Therapeutics's industry is recorded as pharmaceutical industry[8].
- January 1, 2013 marks the founding of Cidara Therapeutics[9].
- Cidara Therapeutics's official website is recorded as https://www.cidara.com/[10].
- Cidara Therapeutics's legal form is recorded as Delaware corporation[11].
- Cidara Therapeutics's legal form is recorded as XTIQ[12].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300IHQ9Z7RI1X2D22[13]
-
Registered legal name: Cidara Therapeutics, INC.[14]
-
Legal jurisdiction: US-DE[15]
-
GLEIF entity category: GENERAL[16]
-
Legal form (ISO 20275 ELF): XTIQ[17]
-
Entity status: ACTIVE[18]
-
LEI registration status: LAPSED[19]
-
LEI first registered: 2015-04-01[20]
-
LEI last updated: 2023-08-04[21]
-
LEI next renewal: 2022-04-09[22]
-
Managing LOU: 5493001KJTIIGC8Y1R12[23]
-
Registration authority: RA000602[24]
-
Authority entity ID: 5251363[25]
-
Other names: K2 Therapeutics, Inc.[26]
-
Conformity flag: NON_CONFORMING[27]
Body
Founding
January 1, 2013 marks the founding of Cidara Therapeutics[9].
Operations
Cidara Therapeutics's headquarters location is recorded as San Diego[6].
Industry
Cidara Therapeutics's industry is recorded as pharmaceutical industry[8].
Ownership
Cidara Therapeutics's stock exchange is recorded as Nasdaq[7].